HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
NCT06014190
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
460
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Endometrial Cancer
Interventions
DRUG:
HS-20089
Sponsor
Hansoh BioMedical R&D Company